Published in PLoS One on January 06, 2009
The Effect of Diflunisal on Familial Amyloidosis | NCT00294671
Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses. Curr Opin Struct Biol (2010) 1.62
Acute phase reactants as novel predictors of cardiovascular disease. ISRN Inflamm (2012) 0.87
Novel transthyretin amyloid fibril formation inhibitors: synthesis, biological evaluation, and X-ray structural analysis. PLoS One (2009) 0.84
Inhibition of human transthyretin aggregation by non-steroidal anti-inflammatory compounds: a structural and thermodynamic analysis. Int J Mol Sci (2013) 0.82
Does transthyretin function as one of contributors for preeclampsia? Med Hypotheses (2010) 0.81
Modifications of the 7-Hydroxyl Group of the Transthyretin Ligand Luteolin Provide Mechanistic Insights into Its Binding Properties and High Plasma Specificity. PLoS One (2016) 0.75
Tetrabromobisphenol A Is an Efficient Stabilizer of the Transthyretin Tetramer. PLoS One (2016) 0.75
Non-covalent interactions involving halogenated derivatives of capecitabine and thymidylate synthase: a computational approach. Springerplus (2016) 0.75
Protective effect of 3,5,3'-triiodothyroacetic and 3,5,3',5'-tetraiodothyroacetic acids on serum albumin fibrillation. Eur Biophys J (2009) 0.75
The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88
Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr (1997) 137.43
Likelihood-enhanced fast translation functions. Acta Crystallogr D Biol Crystallogr (2005) 29.38
Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem (2006) 22.87
Halogen bonds in biological molecules. Proc Natl Acad Sci U S A (2004) 7.19
A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J Med Chem (1985) 6.09
Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A. J Mol Biol (1978) 4.47
Databases in protein crystallography. Acta Crystallogr D Biol Crystallogr (1998) 4.18
Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med (2004) 3.93
The structural basis of protein folding and its links with human disease. Philos Trans R Soc Lond B Biol Sci (2001) 3.65
Retinol-binding protein: the transport protein for vitamin A in human plasma. J Clin Invest (1968) 3.52
Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci U S A (1990) 2.87
Prevention of transthyretin amyloid disease by changing protein misfolding energetics. Science (2003) 2.63
Rational design of potent human transthyretin amyloid disease inhibitors. Nat Struct Biol (2000) 2.57
An experimental survey of the transition between two-state and downhill protein folding scenarios. Proc Natl Acad Sci U S A (2008) 2.57
Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses. Acc Chem Res (2005) 2.25
Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity. Proc Natl Acad Sci U S A (2002) 2.25
Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. Biochemistry (2004) 2.08
Inhibiting transthyretin amyloid fibril formation via protein stabilization. Proc Natl Acad Sci U S A (1996) 1.97
The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve (2007) 1.86
Hydroxylated polychlorinated biphenyls selectively bind transthyretin in blood and inhibit amyloidogenesis: rationalizing rodent PCB toxicity. Chem Biol (2004) 1.76
Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants. J Biol Chem (2001) 1.70
Transthyretin mutations in hyperthyroxinemia and amyloid diseases. Hum Mutat (2001) 1.67
Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis. J Med Chem (2004) 1.54
Structure-dependent, competitive interaction of hydroxy-polychlorobiphenyls, -dibenzo-p-dioxins and -dibenzofurans with human transthyretin. Chem Biol Interact (1993) 1.52
Recent developments for the efficient crystallographic refinement of macromolecular structures. Curr Opin Struct Biol (1998) 1.50
Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants. Lab Invest (2004) 1.50
Discovering transthyretin amyloid fibril inhibitors by limited screening. Bioorg Med Chem (1998) 1.47
Benzoxazoles as transthyretin amyloid fibril inhibitors: synthesis, evaluation, and mechanism of action. Angew Chem Int Ed Engl (2003) 1.39
Synthesis and evaluation of inhibitors of transthyretin amyloid formation based on the non-steroidal anti-inflammatory drug, flufenamic acid. Bioorg Med Chem (1999) 1.38
Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis. Amyloid (2006) 1.34
The pathway by which the tetrameric protein transthyretin dissociates. Biochemistry (2005) 1.32
Thyroxine binding to transthyretin Met 119. Comparative studies of different heterozygotic carriers and structural analysis. Endocrine (1997) 1.27
Quantification of the thermodynamically linked quaternary and tertiary structural stabilities of transthyretin and its disease-associated variants: the relationship between stability and amyloidosis. Biochemistry (2008) 1.26
Synthesis, structure, and activity of diclofenac analogues as transthyretin amyloid fibril formation inhibitors. J Med Chem (2002) 1.22
Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis. Neurosci Res (2006) 1.20
Bisaryloxime ethers as potent inhibitors of transthyretin amyloid fibril formation. J Med Chem (2005) 1.19
Synthesis and evaluation of anthranilic acid-based transthyretin amyloid fibril inhibitors. Bioorg Med Chem Lett (1999) 1.19
Kinetic stabilization of an oligomeric protein by a single ligand binding event. J Am Chem Soc (2005) 1.18
Biochemical and structural evaluation of highly selective 2-arylbenzoxazole-based transthyretin amyloidogenesis inhibitors. J Med Chem (2007) 1.17
The modulation of transthyretin tetramer stability by cysteine 10 adducts and the drug diflunisal. Direct analysis by fluorescence-detected analytical ultracentrifugation. J Biol Chem (2008) 1.16
Kinetic stabilization of the native state by protein engineering: implications for inhibition of transthyretin amyloidogenesis. J Mol Biol (2005) 1.14
Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis. Proc Natl Acad Sci U S A (2005) 1.12
Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization. J Am Chem Soc (2003) 1.12
Anion shielding of electrostatic repulsions in transthyretin modulates stability and amyloidosis: insight into the chaotrope unfolding dichotomy. Biochemistry (2001) 1.10
Toward optimization of the linker substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies. J Med Chem (2008) 1.10
Studies on thyroid hormone-binding proteins. II. Binding of thyroid hormones, retinol-binding protein, and fluorescent probes to prealbumin and effects of thyroxine on prealbumin subunit self association. J Biol Chem (1975) 1.09
Structural insight into pH-induced conformational changes within the native human transthyretin tetramer. J Mol Biol (2008) 1.08
Synthesis and evaluation of transthyretin amyloidosis inhibitors containing carborane pharmacophores. Proc Natl Acad Sci U S A (2007) 1.06
Kinetic stabilization of an oligomeric protein under physiological conditions demonstrated by a lack of subunit exchange: implications for transthyretin amyloidosis. Biochemistry (2005) 1.05
Human-murine transthyretin heterotetramers are kinetically stable and non-amyloidogenic. A lesson in the generation of transgenic models of diseases involving oligomeric proteins. J Biol Chem (2007) 1.04
Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative. Biochem J (2004) 1.04
Drug-protein binding sites. New trends in analytical and experimental methodology. J Chromatogr B Biomed Appl (1996) 1.03
Potent and selective structure-based dibenzofuran inhibitors of transthyretin amyloidogenesis: kinetic stabilization of the native state. J Am Chem Soc (2005) 1.01
Review: TTR amyloidosis-structural features leading to protein aggregation and their implications on therapeutic strategies. J Struct Biol (2000) 1.01
Transport of thyroid hormones in serum and cerebrospinal fluid. J Clin Endocrinol Metab (1973) 1.01
Transthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolution. J Mol Biol (2001) 0.97
Partitioning conformational intermediates between competing refolding and aggregation pathways: insights into transthyretin amyloid disease. Biochemistry (2005) 0.97
A review of the amyloidoses that infiltrate the heart. Clin Cardiol (1998) 0.93
Cell based screening of inhibitors of transthyretin aggregation. Biochem Biophys Res Commun (2006) 0.91
An x-ray study of the subunit structure of prealbumin. J Mol Biol (1971) 0.91
Fourier transform infrared spectroscopy provides a fingerprint for the tetramer and for the aggregates of transthyretin. Biophys J (2006) 0.91
Design, synthesis, and evaluation of oxazole transthyretin amyloidogenesis inhibitors. Bioorg Med Chem Lett (2005) 0.88
Kinetic assay for high-throughput screening of in vitro transthyretin amyloid fibrillogenesis inhibitors. J Comb Chem (2005) 0.86
Human transthyretin in complex with iododiflunisal: structural features associated with a potent amyloid inhibitor. Biochem J (2005) 0.84
Small transthyretin (TTR) ligands as possible therapeutic agents in TTR amyloidoses. Curr Drug Targets CNS Neurol Disord (2005) 0.83
In vivo stabilization of mutant human transthyretin in transgenic mice. Amyloid (2007) 0.81
The chemistry, pharmacology and clinical pharmacology of diflunisal. Curr Med Res Opin (1978) 0.78
A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats. Hum Mutat (2013) 1.53
In vitro synthesis of a crystalline (1-->3,1-->4)-beta-D-glucan by a mutated (1-->3,1-->4)-beta-D-glucanase from Bacillus. Biochem J (2004) 1.42
The family 11 carbohydrate-binding module of Clostridium thermocellum Lic26A-Cel5E accommodates beta-1,4- and beta-1,3-1,4-mixed linked glucans at a single binding site. J Biol Chem (2004) 1.30
How family 26 glycoside hydrolases orchestrate catalysis on different polysaccharides: structure and activity of a Clostridium thermocellum lichenase, CtLic26A. J Biol Chem (2005) 1.13
Conformational analyses of the reaction coordinate of glycosidases. Acc Chem Res (2011) 1.11
The crystal structure of the family 6 carbohydrate binding module from Cellvibrio mixtus endoglucanase 5a in complex with oligosaccharides reveals two distinct binding sites with different ligand specificities. J Biol Chem (2004) 1.08
Scientific competency questions as the basis for semantically enriched open pharmacological space development. Drug Discov Today (2013) 1.04
Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative. Biochem J (2004) 1.04
Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity. FEBS Lett (2009) 1.01
Dihydroxyxanthones prenylated derivatives: synthesis, structure elucidation, and growth inhibitory activity on human tumor cell lines with improvement of selectivity for MCF-7. Bioorg Med Chem (2007) 1.01
The conformational free energy landscape of beta-D-glucopyranose. Implications for substrate preactivation in beta-glucoside hydrolases. J Am Chem Soc (2007) 1.00
The crystal and solution structures of glyceraldehyde-3-phosphate dehydrogenase reveal different quaternary structures. J Biol Chem (2006) 1.00
Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation. FEBS Lett (2011) 1.00
Cyclization of carbonyl groups onto alkynes upon reaction with IPy2BF4 and their trapping with nucleophiles: a versatile trigger for assembling oxygen heterocycles. J Am Chem Soc (2003) 0.99
Annotating Human P-Glycoprotein Bioassay Data. Mol Inform (2012) 0.98
Bromoalkoxyxanthones as promising antitumor agents: synthesis, crystal structure and effect on human tumor cell lines. Eur J Med Chem (2009) 0.96
Copper(II) tetrafluoroborate catalyzed ring-opening reaction of epoxides with alcohols at room temperature. Org Lett (2002) 0.96
In vitro synthesis of artificial polysaccharides by glycosidases and glycosynthases. Carbohydr Res (2007) 0.94
Structural basis for the substrate specificity of a Bacillus 1,3-1,4-beta-glucanase. J Mol Biol (2006) 0.94
Intramolecular diamination of alkenes with palladium(II)/copper(II) bromide and IPy2BF4: the role of halogenated intermediates. Chem Asian J (2008) 0.93
Interaction with human plasminogen system turns on proteolytic activity in Streptococcus agalactiae and enhances its virulence in a mouse model. Microbes Infect (2007) 0.93
Anti-apoptotic treatment reduces transthyretin deposition in a transgenic mouse model of Familial Amyloidotic Polyneuropathy. Biochim Biophys Acta (2008) 0.92
Stereoselective Michael Addition of Glycine Anions to Chiral Fischer Alkenylcarbene Complexes. Asymmetric Synthesis of beta-Substituted Glutamic Acids. J Org Chem (1999) 0.91
Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: "in vivo" evidence from FAP mice models. PLoS One (2012) 0.91
Heparan sulfate/heparin promotes transthyretin fibrillization through selective binding to a basic motif in the protein. Proc Natl Acad Sci U S A (2011) 0.91
Chemical rescue of alpha3-galactosyltransferase. Implications in the mechanism of retaining glycosyltransferases. J Am Chem Soc (2006) 0.90
The binding of xanthone derivatives to transthyretin. Biochem Pharmacol (2005) 0.89
Molecular mechanisms of disease for mutations at Gly-90 in rhodopsin. J Biol Chem (2011) 0.88
A generic crystallization-like model that describes the kinetics of amyloid fibril formation. J Biol Chem (2012) 0.88
Substrate distortion in the Michaelis complex of Bacillus 1,3-1,4-beta-glucanase. Insight from first principles molecular dynamics simulations. J Biol Chem (2005) 0.88
The crystal structure of transthyretin in complex with diethylstilbestrol: a promising template for the design of amyloid inhibitors. J Biol Chem (2004) 0.88
Structural basis of chitin oligosaccharide deacetylation. Angew Chem Int Ed Engl (2014) 0.88
Kinetic assay for high-throughput screening of in vitro transthyretin amyloid fibrillogenesis inhibitors. J Comb Chem (2005) 0.86
Withanolides from Withania aristata and their cytotoxic activity. Steroids (2010) 0.86
The conformational free-energy landscape of β-D-mannopyranose: evidence for a (1)S(5) → B(2,5) → (O)S(2) catalytic itinerary in β-mannosidases. J Am Chem Soc (2010) 0.85
Applicability Domain ANalysis (ADAN): a robust method for assessing the reliability of drug property predictions. J Chem Inf Model (2014) 0.85
Re-engineering specificity in 1,3-1, 4-β-glucanase to accept branched xyloglucan substrates. Proteins (2011) 0.85
Dietary curcumin counteracts extracellular transthyretin deposition: insights on the mechanism of amyloid inhibition. Biochim Biophys Acta (2012) 0.85
Glycosynthase activity of Bacillus licheniformis 1,3-1,4-beta-glucanase mutants: specificity, kinetics, and mechanism. Biochemistry (2003) 0.85
Comparative effects of horse exercise versus traditional exercise programs on gait, muscle strength, and body balance in healthy older adults. J Aging Phys Act (2014) 0.84
Nonsequence-specific arginine interactions in the nucleosome core particle. Biopolymers (2003) 0.84
Human transthyretin in complex with iododiflunisal: structural features associated with a potent amyloid inhibitor. Biochem J (2005) 0.84
Active-site mapping of a Populus xyloglucan endo-transglycosylase with a library of xylogluco-oligosaccharides. J Biol Chem (2008) 0.84
Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration. Acta Neuropathol (2014) 0.84
Expression and characterization of a Mycoplasma genitalium glycosyltransferase in membrane glycolipid biosynthesis: potential target against mycoplasma infections. J Biol Chem (2011) 0.83
Hydroxymethyl rotamer populations in disaccharides. J Org Chem (2003) 0.83
Acceptor-dependent regioselectivity of glycosynthase reactions by Streptomyces E383A beta-glucosidase. Carbohydr Res (2006) 0.83
Structural analysis of the inhibition of Cdk4 and Cdk6 by p16(INK4a) through molecular dynamics simulations. J Biomol Struct Dyn (2002) 0.83
Formation of a covalent glycosyl-enzyme species in a retaining glycosyltransferase. Chemistry (2013) 0.82
Functional characterization of Arabidopsis thaliana transthyretin-like protein. BMC Plant Biol (2010) 0.82
Synthesis of a library of xylogluco-oligosaccharides for active-site mapping of xyloglucan endo-transglycosylase. J Org Chem (2006) 0.82
Thermus thermophilus glycoside hydrolase family 57 branching enzyme: crystal structure, mechanism of action, and products formed. J Biol Chem (2010) 0.82
Molecular tweezers targeting transthyretin amyloidosis. Neurotherapeutics (2014) 0.82
Critical role of electrostatic interactions of amino acids at the cytoplasmic region of helices 3 and 6 in rhodopsin conformational properties and activation. J Biol Chem (2007) 0.82
1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor. Bioorg Med Chem (2008) 0.81
Experimental study of visual training effects in shooting initiation. Clin Exp Optom (2002) 0.81
Structure and assembly-disassembly properties of wild-type transthyretin amyloid protofibrils observed with atomic force microscopy. J Mol Recognit (2011) 0.81
Conformational analysis of a cyclopropane analogue of phenylalanine with two geminal phenyl substituents. J Phys Chem B (2006) 0.81
Conformational domino effect in saccharides. 2. Anomeric configuration control. J Org Chem (2008) 0.81
Kinetic analysis using low-molecular mass xyloglucan oligosaccharides defines the catalytic mechanism of a Populus xyloglucan endotransglycosylase. Biochem J (2006) 0.81
Comparative in vitro and ex vivo activities of selected inhibitors of transthyretin aggregation: relevance in drug design. Biochem J (2007) 0.80
Synthesis, conformation, and biological characterization of a sugar derivative of morphine that is a potent, long-lasting, and nontolerant antinociceptive. J Med Chem (2009) 0.80
Mechanism-based labeling defines the free energy change for formation of the covalent glycosyl-enzyme intermediate in a xyloglucan endo-transglycosylase. J Biol Chem (2008) 0.80
Modulation of the fibrillogenesis inhibition properties of two transthyretin ligands by halogenation. J Med Chem (2013) 0.80
Gene ontology function prediction in mollicutes using protein-protein association networks. BMC Syst Biol (2011) 0.80
Iodination of salicylic acid improves its binding to transthyretin. Biochim Biophys Acta (2007) 0.80
Merodrimanes and other constituents from Talaromyces thailandiasis. J Nat Prod (2007) 0.80
Understanding water equilibration fundamentals as a step for rational protein crystallization. PLoS One (2008) 0.80
New serotonin 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptor antagonists: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo and heterocycloalkanones. J Med Chem (2002) 0.79
Supramolecular helical stacking of metallomesogens derived from enantiopure and racemic polycatenar oxazolines. J Am Chem Soc (2003) 0.79
Capillary HPLC-ICPMS and tyrosine iodination for the absolute quantification of peptides using generic standards. Anal Chem (2009) 0.79
Transthyretin aggregate-specific antibodies recognize cryptic epitopes on patient-derived amyloid fibrils. Rejuvenation Res (2014) 0.79
Formal alkyne insertion into alkoxycarbene complexes: simple access to enantiopure group 6 alkynyl(alkoxy)carbene complexes. Angew Chem Int Ed Engl (2005) 0.79
Regioselective postsynthetic modification of phenylalanine side chains of peptides leading to uncommon ortho-iodinated analogues. Angew Chem Int Ed Engl (2004) 0.79
Arylation of Phe and Tyr side chains of unprotected peptides by a Suzuki-Miyaura reaction in water. Org Lett (2008) 0.79
Structure-activity relationship study of opiorphin, a human dual ectopeptidase inhibitor with antinociceptive properties. J Med Chem (2012) 0.78
Conformational domino effect in saccharides: a prediction from alkyl beta-(1-->6)-diglucopyranosides. J Org Chem (2008) 0.78